Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (5758)	2/27/2002 9:20:02 AM
From: Ian@SI	Read Replies (1) \| Respond to of 52153

Is there any way of knowing when the data could be available from the German trial now underway? i.e. - How realistic is the expectation of Erbitux approval by next spring? Thanks, Ian ++++++++++ 02/27 08:58 ImClone Asks FDA to Review Results of European Erbitux Tests By Angela Zimm New York, Feb. 27 (Bloomberg) -- ImClone Systems Inc. said it asked U.S. regulators to consider results of U.S. and European trials of its stalled Erbitux cancer drug. ImClone and partner Bristol-Myers Squibb Co. met with the U.S. Food and Drug Administration yesterday to discuss what further steps the agency might require before it will review the Erbitux application, which the agency refused to consider in December. ImClone ``discussed an approach'' in which the FDA would review results of tests already conducted in the U.S. and ongoing trials in Europe, the company said in a faxed statement. ImClone shares rose as high as $23.50 in Instinet trading before the opening of U.S. markets, after closing at $15.52 yesterday.

To: Biomaven who wrote (5758)	2/27/2002 9:24:37 AM
From: jayhawk969	Read Replies (2) \| Respond to of 52153

My suspicion after hearing about the results of yesterday's IMCL meeting was that there was a "pre-leak" from that meeting. Note the stock jumped yesterday at the open, before the meeting started. There has been heavy IMCL shorting with some discussion on the SI short threads. OK, Lets assume that the "leak" caused the turnaround in the biotech market, which if I remember started about 10:30 Eastern, and really kicked into high gear in the afternoon. For this much buying to occur in PDLI, MYGN, ELN, SEPR, NIBX, MLNM, HGSI, etc. the rumor must of spread very quickly and involved a lot of institutional people. And the institution that was selling 25,000 shares every time SEPR went up $.20 was not clued in. How do we get the inside information on yesterdays trigger?